Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16.
Lancet Oncol. 2019.
PMID: 31003911
Clinical Trial.
Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E, Bien E, Stefanowicz J, Szurowska E, Szutowicz-Zielinska E, Koczkowska M, Sigorski D, Kloc W, Rogowski W, Adamkiewicz-Drozynska E.
Izycka-Swieszewska E, et al. Among authors: szutowicz zielinska e.
Biomed Res Int. 2018 Apr 1;2018:4596812. doi: 10.1155/2018/4596812. eCollection 2018.
Biomed Res Int. 2018.
PMID: 29805974
Free PMC article.
Item in Clipboard
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
Woditschka S, Evans L, Duchnowska R, Reed LT, Palmieri D, Qian Y, Badve S, Sledge G Jr, Gril B, Aladjem MI, Fu H, Flores NM, Gökmen-Polar Y, Biernat W, Szutowicz-Zielińska E, Mandat T, Trojanowski T, Och W, Czartoryska-Arlukowicz B, Jassem J, Mitchell JB, Steeg PS.
Woditschka S, et al. Among authors: szutowicz zielinska e.
J Natl Cancer Inst. 2014 Jun 19;106(7):dju145. doi: 10.1093/jnci/dju145. Print 2014 Jul.
J Natl Cancer Inst. 2014.
PMID: 24948741
Free PMC article.
Item in Clipboard
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M, Thatcher N, Smit EF, Lorigan P, Szutowicz-Zielinska E, Liepa AM, Winfree KB, Peterson P, Guba SC, Socinski MA.
Reck M, et al. Among authors: szutowicz zielinska e.
Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6.
Lung Cancer. 2012.
PMID: 23043970
Item in Clipboard
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Szutowicz-Zielińska E, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M.
Pellanda AF, et al. Among authors: szutowicz zielinska e.
Chin J Cancer Res. 2017 Dec;29(6):521-532. doi: 10.21147/j.issn.1000-9604.2017.06.06.
Chin J Cancer Res. 2017.
PMID: 29353974
Free PMC article.
Item in Clipboard
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Szutowicz-Zielińska E, Konopa K, Kowalczyk A, Suszko-Każarnowicz M, Duchnowska R, Szczęsna A, Ratajska M, Sowa A, Limon J, Biernat W, Burzykowski T, Jassem J, Dziadziuszko R.
Szutowicz-Zielińska E, et al.
Oncotarget. 2017 Mar 7;8(10):17270-17278. doi: 10.18632/oncotarget.13793.
Oncotarget. 2017.
PMID: 27924059
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite